Singapore markets closed

Eli Lilly and Company (LLY)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
726.31-19.64 (-2.63%)
At close: 04:00PM EDT
722.10 -4.21 (-0.58%)
After hours: 07:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
34,124,100
34,124,100
28,541,400
28,318,400
24,539,800
Cost of revenue
7,082,200
7,082,200
6,629,800
7,312,800
5,483,300
Gross profit
27,041,900
27,041,900
21,911,600
21,005,600
19,056,500
Operating expenses
Research development
9,313,400
9,313,400
7,190,800
6,930,700
6,085,700
Selling general and administrative
6,941,200
6,941,200
6,067,500
6,141,900
5,869,400
Total operating expenses
16,254,600
16,254,600
13,258,300
13,072,600
11,955,100
Operating income or loss
10,787,300
10,787,300
8,653,300
7,933,000
7,101,400
Interest expense
485,900
485,900
331,600
339,800
359,600
Total other income/expenses net
-3,920,400
-3,920,400
-1,578,100
-1,463,100
455,100
Income before tax
6,554,600
6,554,600
6,806,400
6,155,500
7,229,900
Income tax expense
1,314,200
1,314,200
561,600
573,800
1,036,200
Income from continuing operations
5,240,400
5,240,400
6,244,800
5,581,700
6,193,700
Net income
5,240,400
5,240,400
6,244,800
5,581,700
6,193,700
Net income available to common shareholders
5,240,400
5,240,400
6,244,800
5,581,700
6,193,700
Basic EPS
5.54
5.82
6.57
5.85
6.47
Diluted EPS
5.52
5.80
6.57
5.85
6.47
Basic average shares
900,536
900,181
950,182
953,653
956,590
Diluted average shares
903,569
903,284
950,182
953,653
956,590